Usa virus covid-19 vaccine infection Usa

Inside the race to crack the Covid-19 vaccine

Reading now: 218
www.livemint.com

Something strange happened. On Monday, 18 May, Moderna, a biotech company based in the US, held a press conference in which it released positive preliminary data on its ongoing vaccine program for covid-19.

Its stock price reached stratospheric heights. The following day, perhaps suffering from the hangover of the initial euphoria, with the sobering realization that there is still a long way to go before any vaccine can be deemed successful, Moderna’s share price started to slide.

We really need a vaccine. SARS-CoV-2, the pandemic coronavirus that causes covid-19 has infected over five million people globally.

Ravaging much of Asia, Europe, and North America, it is now intensifying in South America and Africa. Because it is a new virus

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA